OMER Executive Compensation
* In USD (Original Currency)
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
---|---|---|---|---|---|---|---|---|
2023-05-17 | 2021 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 401,700 | 97,000 | 0 | 0 | 6,625 | 1,278,638 |
2023-05-17 | 2020 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 384,016 | 153,178 | 0 | 0 | 6,555 | 1,093,964 |
2023-05-17 | 2022 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 429,936 | 81,120 | 0 | 0 | 7,541 | 771,511 |
2023-05-17 | 2020 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 817,405 | 1,400,000 | 0 | 0 | 20,654 | 5,775,149 |
2023-05-17 | 2021 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 848,103 | 875,000 | 0 | 0 | 21,609 | 7,415,675 |
2023-05-17 | 2022 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 882,027 | 890,000 | 0 | 0 | 22,607 | 3,728,686 |
2023-05-17 | 2021 | Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary | 381,600 | 90,000 | 0 | 0 | 6,594 | 1,251,507 |
2023-05-17 | 2020 | Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary | 345,000 | 57,500 | 0 | 0 | 6,607 | 943,719 |
2023-05-17 | 2022 | Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary | 417,960 | 77,760 | 0 | 0 | 7,516 | 741,273 |
2022-05-02 | 2020 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 384,016 | 153,178 | 0 | 0 | 6,555 | 1,093,964 |
2022-05-02 | 2021 | Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary | 381,600 | 90,000 | 0 | 0 | 6,594 | 1,251,507 |
2022-05-02 | 2020 | Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary | 345,000 | 57,500 | 0 | 0 | 6,607 | 943,719 |
2022-05-02 | 2019 | Peter B. Cancelmo, J.D. Vice President, General Counsel and Secretary | 287,500 | 15,000 | 0 | 0 | 5,413 | 705,959 |
2022-05-02 | 2021 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 848,103 | 875,000 | 0 | 0 | 21,609 | 7,415,675 |
2022-05-02 | 2021 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 401,700 | 97,000 | 0 | 0 | 6,625 | 1,278,638 |
2022-05-02 | 2019 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 793,597 | 0 | 0 | 0 | 20,217 | 4,825,134 |
2022-05-02 | 2020 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 817,405 | 1,400,000 | 0 | 0 | 20,654 | 5,775,149 |
2022-05-02 | 2019 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 363,398 | 0 | 0 | 0 | 6,556 | 983,450 |
2021-04-30 | 2019 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 793,597 | 0 | 0 | 0 | 20,217 | 4,825,134 |
2021-04-30 | 2020 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 817,405 | 1,400,000 | 0 | 0 | 20,654 | 5,775,149 |
2021-04-30 | 2018 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board | 770,483 | 700,000 | 0 | 0 | 19,581 | 4,740,339 |
2021-04-30 | 2020 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 384,016 | 153,178 | 0 | 0 | 6,555 | 1,093,964 |
2021-04-30 | 2019 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 363,398 | 0 | 0 | 0 | 6,556 | 983,450 |
2021-04-30 | 2018 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 352,814 | 69,010 | 0 | 0 | 6,630 | 985,644 |
2021-04-30 | 2020 | Peter B. Cancelmo, J.D. Vice President, General Counsel | 345,000 | 57,500 | 0 | 0 | 6,607 | 943,719 |
2021-04-30 | 2019 | Peter B. Cancelmo, J.D. Vice President, General Counsel | 287,500 | 15,000 | 0 | 0 | 5,413 | 705,959 |
2020-04-29 | 2018 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 352,814 | 69,010 | 0 | 0 | 6,630 | 985,644 |
2020-04-29 | 2019 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 363,398 | 0 | 0 | 0 | 6,556 | 983,450 |
2020-04-29 | 2017 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 748,041 | 901,725 | 0 | 0 | 20,555 | 4,535,284 |
2020-04-29 | 2018 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 770,483 | 700,000 | 0 | 0 | 19,581 | 4,740,339 |
2020-04-29 | 2019 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 793,597 | 0 | 0 | 0 | 20,217 | 4,825,134 |
2020-04-29 | 2017 | Marcia S. Kelbon, J.D., M.S. Former Vice President, Patents, General Counsel and Secretary | 381,287 | 258,121 | 0 | 0 | 6,651 | 1,219,052 |
2020-04-29 | 2018 | Marcia S. Kelbon, J.D., M.S. Former Vice President, Patents, General Counsel and Secretary | 397,095 | 77,671 | 0 | 0 | 6,693 | 1,085,082 |
2020-04-29 | 2019 | Marcia S. Kelbon, J.D., M.S. Former Vice President, Patents, General Counsel and Secretary | 409,008 | 90,002 | 0 | 0 | 6,618 | 1,119,124 |
2020-04-29 | 2019 | Peter B. Cancelmo, J.D. | 287,500 | 15,000 | 0 | 0 | 5,413 | 705,959 |
2020-04-29 | 2017 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 338,769 | 136,179 | 0 | 0 | 6,586 | 1,016,327 |
2019-04-29 | 2017 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-29 | 2016 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-29 | 2016 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-29 | 2016 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-29 | 2017 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-29 | 2018 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-29 | 2017 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-29 | 2018 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-29 | 2018 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
2018-04-30 | 2017 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 338,769 | 136,179 | 0 | 0 | 6,586 | 1,016,327 |
2018-04-30 | 2017 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 748,041 | 901,725 | 0 | 0 | 20,555 | 4,535,283 |
2018-04-30 | 2016 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 776,918 | 248,595 | 0 | 0 | 15,163 | 6,380,956 |
2018-04-30 | 2015 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 669,500 | 0 | 0 | 0 | 14,092 | 683,592 |
2018-04-30 | 2016 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 336,778 | 51,880 | 0 | 0 | 2,573 | 1,526,041 |
2018-04-30 | 2015 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 285,000 | 0 | 0 | 0 | 2,545 | 287,545 |
2018-04-30 | 2017 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 381,287 | 258,121 | 0 | 0 | 6,651 | 1,219,051 |
2018-04-30 | 2016 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 400,412 | 64,061 | 0 | 0 | 2,619 | 1,535,148 |
2018-04-30 | 2015 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 345,050 | 0 | 0 | 0 | 2,640 | 347,690 |
2017-04-25 | 2016 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 336,778 | 51,880 | 0 | 0 | 2,573 | 1,526,041 |
2017-04-25 | 2014 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 352,587 | 0 | 0 | 0 | 2,456 | 1,146,240 |
2017-04-25 | 2015 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 345,050 | 0 | 0 | 0 | 2,640 | 347,690 |
2017-04-25 | 2016 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 400,412 | 64,061 | 0 | 0 | 2,619 | 1,535,148 |
2017-04-25 | 2014 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 285,000 | 0 | 0 | 0 | 2,398 | 1,007,118 |
2017-04-25 | 2015 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 285,000 | 0 | 0 | 0 | 2,545 | 287,545 |
2017-04-25 | 2016 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 776,918 | 248,595 | 0 | 0 | 15,163 | 6,380,956 |
2017-04-25 | 2015 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 669,500 | 0 | 0 | 0 | 14,092 | 683,592 |
2017-04-25 | 2014 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 684,125 | 0 | 0 | 0 | 17,195 | 3,938,035 |
2016-04-22 | 2015 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
2016-04-22 | 2013 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2016-04-22 | 2014 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2016-04-22 | 2015 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2016-04-22 | 2013 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2016-04-22 | 2014 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2016-04-22 | 2015 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2016-04-22 | 2013 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
2016-04-22 | 2014 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
2015-04-23 | 2012 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 655,500 | 108,150 | 0 | 0 | 18,342 | 3,534,927 |
2015-04-23 | 2013 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 79,745 | 0 | 0 | 0 | 717 | 787,233 |
2015-04-23 | 2012 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2015-04-23 | 2014 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 352,587 | 0 | 0 | 0 | 2,456 | 1,146,240 |
2015-04-23 | 2013 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 335,000 | 0 | 0 | 0 | 2,169 | 1,037,605 |
2015-04-23 | 2012 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 338,050 | 55,878 | 0 | 0 | 3,539 | 1,399,656 |
2015-04-23 | 2014 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 684,125 | 0 | 0 | 0 | 17,195 | 3,938,035 |
2015-04-23 | 2013 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 650,000 | 0 | 0 | 0 | 14,881 | 3,236,359 |
2015-04-23 | 2014 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 285,000 | 0 | 0 | 0 | 2,398 | 1,007,118 |
2014-04-24 | 2013 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 664,625 | 0 | 0 | 0 | 14,881 | 3,250,984 |
2014-04-24 | 2012 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 338,050 | 55,878 | 0 | 0 | 3,539 | 1,399,656 |
2014-04-24 | 2013 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 342,538 | 0 | 0 | 0 | 2,169 | 1,045,143 |
2014-04-24 | 2011 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2014-04-24 | 2012 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2014-04-24 | 2013 | Michael A. Jacobsen Vice President, Finance, Chief Accounting Officer and Treasurer | 79,745 | 0 | 0 | 0 | 717 | 786,516 |
2014-04-24 | 2011 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 600,000 | 0 | 0 | 0 | 17,349 | 617,349 |
2014-04-24 | 2012 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 655,500 | 108,150 | 0 | 0 | 18,342 | 3,534,927 |
2014-04-24 | 2011 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 310,000 | 0 | 0 | 0 | 3,813 | 313,813 |
2013-04-24 | 2011 | Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors and Interim Chief Financial Officer and Treasurer | 600,000 | 0 | 0 | 0 | 17,349 | 617,349 |
2013-04-24 | 2012 | Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors and Interim Chief Financial Officer and Treasurer | 655,500 | 108,150 | 0 | 0 | 18,342 | 3,534,927 |
2013-04-24 | 2010 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 305,833 | 0 | 0 | 47,244 | 3,729 | 734,365 |
2013-04-24 | 2011 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 310,000 | 0 | 0 | 0 | 3,813 | 313,813 |
2013-04-24 | 2012 | Marcia S. Kelbon, J.D., M.S. Vice President, Patent and General Counsel and Secretary | 338,050 | 55,878 | 0 | 0 | 3,539 | 1,399,656 |
2013-04-24 | 2010 | Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors and Interim Chief Financial Officer and Treasurer | 579,167 | 0 | 0 | 91,440 | 23,635 | 2,093,530 |
2012-04-27 | 2009 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 285,000 | 0 | 0 | 0 | 3,672 | 288,672 |
2012-04-27 | 2010 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 305,833 | 0 | 0 | 47,244 | 3,729 | 734,365 |
2012-04-27 | 2011 | Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors | 600,000 | 0 | 0 | 0 | 17,349 | 617,349 |
2012-04-27 | 2010 | Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors | 579,167 | 0 | 0 | 91,440 | 23,635 | 2,093,530 |
2012-04-27 | 2009 | Gregory A. Demopulos, M.D. President, Chief Executive Officer, Chairman of the Board of Directors | 475,000 | 0 | 0 | 0 | 14,003 | 489,003 |
2012-04-27 | 2011 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 310,000 | 0 | 0 | 0 | 3,813 | 313,813 |
2011-04-27 | 2010 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 305,833 | 0 | 0 | 47,244 | 3,729 | 734,365 |
2011-04-27 | 2008 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 285,000 | 0 | 0 | 0 | 3,049 | 288,049 |
2011-04-27 | 2010 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 579,167 | 0 | 0 | 91,440 | 23,635 | 2,093,530 |
2011-04-27 | 2009 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 475,000 | 0 | 0 | 0 | 14,003 | 489,003 |
2011-04-27 | 2008 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 475,000 | 0 | 0 | 0 | 25,255 | 500,255 |
2011-04-27 | 2009 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 285,000 | 0 | 0 | 0 | 3,672 | 288,672 |
2010-04-28 | 2008 | Richard J. Klein Chief Financial Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2010-04-28 | 2009 | Richard J. Klein Chief Financial Officer and Treasurer | 0 | 0 | 0 | 0 | 0 | 0 |
2010-04-28 | 2007 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
2010-04-28 | 2008 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
2010-04-28 | 2009 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2010-04-28 | 2008 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2010-04-28 | 2007 | Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors | 0 | 0 | 0 | 0 | 0 | 0 |
2010-04-28 | 2009 | Marcia S. Kelbon, J.D. Vice President, Patent and General Counsel and Secretary | 0 | 0 | 0 | 0 | 0 | 0 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.